Search

Author/Creator Heinz, W.J.

1. Antifungal prophylaxis with posaconazole suspension versus tablet in pediatric patients after hematopoietic stem cell transplantation. (April 2016)

Authors:
Döring, M.; Cabanillas Stanchi, K.M.; Queudeville, M.; Feucht, J.; Schlegel, P.; Feuchtinger, T.; Lang, P.; Müller, I.; Handgretinger, R.; Heinz, W.J.
Journal:
International journal of infectious diseases
Issue:
Volume 45(2016:Apr.)Supplement 1
Page Start:
312
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. (May 2018)

Authors:
Ullmann, A.J.; Aguado, J.M.; Arikan-Akdagli, S.; Denning, D.W.; Groll, A.H.; Lagrou, K.; Lass-Flörl, C.; Lewis, R.E.; Munoz, P.; Verweij, P.E.; Warris, A.; Ader, F.; Akova, M.; Arendrup, M.C.; Barnes, R.A.; Beigelman-Aubry, C.; Blot, S.; Bouza, E.; Brüggemann, R.J.M.; Buchheidt, D.
Journal:
Clinical microbiology and infection
Issue:
Volume 24: Supplement 1(2018)
Page Start:
e1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1, 3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study. (October 2016)

Authors:
Boch, T.; Spiess, B.; Cornely, O.A.; Vehreschild, J.J.; Rath, P.M.; Steinmann, J.; Heinz, W.J.; Hahn, J.; Krause, S.W.; Kiehl, M.G.; Egerer, G.; Liebregts, T.; Koldehoff, M.; Klein, M.; Nolte, F.; Mueller, M.C.; Merker, N.; Will, S.; Mossner, M.; Popp, H.
Journal:
Clinical microbiology and infection
Issue:
Volume 22:Number 10(2016)
Page Start:
862
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Healthcare burden of probable and proven invasive mucormycosis: a multi-centre cost-of-illness analysis of patients treated in tertiary care hospitals between 2003 and 2016. Issue 3 (March 2019)

Authors:
Heimann, S.M.; Vehreschild, M.J.G.T.; Cornely, O.A.; Heinz, W.J.; Grüner, B.; Silling, G.; Kessel, J.; Seidel, D.; Vehreschild, J.J.
Journal:
Journal of hospital infection
Issue:
Volume 101:Issue 3(2019)
Page Start:
339
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Prospective multicentre PCR-based Aspergillus DNA screening in high-risk patients with and without primary antifungal mould prophylaxis. (January 2016)

Authors:
Springer, J.; Lackner, M.; Nachbaur, D.; Girschikofsky, M.; Risslegger, B.; Mutschlechner, W.; Fritz, J.; Heinz, W.J.; Einsele, H.; Ullmann, A.J.; Löffler, J.; Lass-Flörl, C.
Journal:
Clinical microbiology and infection
Issue:
Volume 22:Number 1(2016)
Page Start:
80
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗